DGAP-News: EQT Partners AB: EQT VI to acquire BSN medical
(firmenpresse) - DGAP-News: EQT Partners AB / Key word(s): Mergers&Acquisitions/Private Equity
EQT Partners AB: EQT VI to acquire BSN medical
11.06.2012 / 10:01
---------------------------------------------------------------------
EQT VI to acquire BSN medical
- EQT VI has agreed to acquire market leading medical supplies
manufacturer BSN medical for an enterprise value of around EUR 1.8
billion
- EQT VI plans to support and accelerate BSN's growth by investing into
the core business and geographic market expansion and by making
targeted add-on acquisitions
- Management intends to reinvest a substantial amount of their
transaction proceeds into BSN medical
EQT VI has agreed to acquire medical supplies manufacturer BSN medical
('BSN' or the 'Company') from Montagu Private Equity and the company's
management for an enterprise value of around EUR 1.8 billion. BSN was
founded in 2001 as a joint venture between Beiersdorf AG and Smith&Nephew, and was acquired by Montagu Private Equity in 2005.
With sales of close to EUR 700 million and approximately 4,000 employees,
BSN is one of the world's leading suppliers of wound care, compression
therapy, and orthopaedic products to hospitals, pharmacies and sanitary
shops.
In the Wound Care segment, the Company's portfolio includes both Acute and
Advanced Wound Care products. The Compression Therapy business focuses,
amongst others, on ready-to-wear and custom-made compression garments,
covering phlebology and lymphology indications. In Orthopaedics, BSN offers
a comprehensive range of products for fracture management, physiotherapy
and orthopaedic soft goods.
BSN is focused on innovation to continuously differentiate the Company's
product portfolio, with many of BSN's well-known brands - Gypsona(R),
Cutimed(R), Actimove(R), Leukoplast(R), JOBST(R), Elvarex(R) and
Delta-Cast(R) - being among the most trusted names in the healthcare
profession.
BSN operates production facilities in Germany, France, Colombia, Mexico,
New Zealand, Pakistan, South Africa, the US and Venezuela, and sells its
products globally - mainly via directly-owned affiliates, but also through
joint ventures and distribution agents.
'We view BSN as a highly attractive growth case with strong resilience
across the business cycle. While continuing to strengthen the position in
key markets and in key product segments, there is tremendous potential in
entering new geographic markets, especially in Asia and Latin America.
BSN's global foot-print and large sales force provide an excellent platform
for add-on acquisitions', says Marcus Brennecke, Partner at EQT Partners in
Germany, Investment Advisor to EQT VI.
'We are very pleased to welcome EQT VI as our new owner and look forward to
working together with EQT VI and the new Supervisory Board to fully realize
the exciting growth potential that BSN has. EQT's experience in improving
global companies and its extensive network of highly relevant Industrial
Advisors will be of great value to BSN and to us as the management team',
says Dr. Claus-H. Wiegel, CEO of BSN.
The transaction is subject to approval from competition and other relevant
authorities.
Morgan Stanley and Deutsche Bank acted as financial advisors to EQT VI.
Contacts
EQT VI Spokesperson
Marcus Brennecke, Partner at EQT Partners Germany, +49 89 25549920
Johan Hähnel, Communications&PR, +46 8 506 55 334
About EQT
EQT is the leading private equity group in Northern Europe with close to
EUR 18 billion in raised capital and multiple investment strategies.
Together with a superior network of independent Industrial Advisors, EQT
implements its investment strategy by acquiring or financing good
medium-sized to large companies in Northern and Eastern Europe, Asia and
the United States, supporting their development into leading companies.
Development is achieved by an industrial strategy with focus on growth.
Since inception, EQT has invested more than EUR 11 billion in around 100
companies and exited close to 50. EQT-owned companies have more than
550,000 employees.
EQT Partners, acting as Investment Advisor to the managers of each EQT
fund, has around 120 investment professionals with an extensive industrial
and financial competence. EQT Partners and its affiliates have offices in
Copenhagen, Frankfurt, Helsinki, Hong Kong, Oslo, London, Munich, New York,
Shanghai, Singapore, Stockholm, Warsaw and Zurich.
More information can be found on www.eqt.se
About BSN medical
BSN medical is a global medical device company and one of the world's
leading suppliers in the product segments of casting, bandaging, wound care
and compression stockings, focusing on developing world-class products that
offer high quality solutions for both caregivers and patients. BSN sells
its products globally via direct affiliates, joint-ventures and
distributors. The company employs more than 4,000 people and has generated
revenues of EUR 665 million in 2011.
More information can be found on www.bsnmedical.com
End of financial news
---------------------------------------------------------------------
11.06.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
173423 11.06.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.06.2012 - 10:01 Uhr
Sprache: Deutsch
News-ID 154840
Anzahl Zeichen: 4583
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 285 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: EQT Partners AB: EQT VI to acquire BSN medical"
steht unter der journalistisch-redaktionellen Verantwortung von
EQT Partners AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
